OBJECTIVE: To characterize an autosomal dominant macular dystrophy with highly variable expression that does not fall clearly into a known disease entity. METHODS AND PATIENTS: Clinical, angiographic, and electrophysiologic data of five affected members in a family of Indian origin were evaluated. Molecular genetic analysis was undertaken to assess whether the gene responsible for the phenotype in this pedigree mapped to a region previously assigned to dominantly inherited macular dystrophies, including North Carolina macular dystrophy. RESULTS: The fundus appearance in the proband simulated stage 3 North Carolina macular dystrophy. Affected relatives had features in common with pattern dystrophy, fundus flavimaculatus with a dark choroi...
PURPOSE: To characterize in detail the phenotype of five unrelated families with autosomal dominant ...
PURPOSE: This study aimed to identify the genetic defects in 2 families with autosomal recessive ma...
Purpose: To clinically and molecularly investigate a new family with North Carolina macular dystroph...
AbstractNorth Carolina macular dystrophy (NCMD) is an autosomal dominant macular disease, was mapped...
Purpose To describe a German family with clinical and genetic evidence of autosomal dominant North ...
Background and objective: North Carolina macular dystrophy (NCMD) is a very rare autosomal dominant ...
Abstract Background This study provides a detailed description of a Chinese family with North Caroli...
The inherited macular dystrophies are characterized by different grade central visual loss and diffe...
The inherited macular dystrophies are characterized by different grade central visual loss and diffe...
It can be clinically challenging to distinguish dry age-related macular degeneration (AMD) from AMD-...
Background: North Carolina macular dystrophy (NCMD) is a rare autosomal dominant maculopathy with hi...
PURPOSE: To describe the clinical findings and to identify the genetic locus in a Dutch family with ...
Aims. We present a familial hereditary macular dystrophy, resembling North Carolina Macular Dystroph...
Retinal dystrophies are a heterogeneous group of diseases that lead to either partial or complete bl...
PURPOSE:To describe the clinical phenotype and the intrafamilial variation in retinal findings in a ...
PURPOSE: To characterize in detail the phenotype of five unrelated families with autosomal dominant ...
PURPOSE: This study aimed to identify the genetic defects in 2 families with autosomal recessive ma...
Purpose: To clinically and molecularly investigate a new family with North Carolina macular dystroph...
AbstractNorth Carolina macular dystrophy (NCMD) is an autosomal dominant macular disease, was mapped...
Purpose To describe a German family with clinical and genetic evidence of autosomal dominant North ...
Background and objective: North Carolina macular dystrophy (NCMD) is a very rare autosomal dominant ...
Abstract Background This study provides a detailed description of a Chinese family with North Caroli...
The inherited macular dystrophies are characterized by different grade central visual loss and diffe...
The inherited macular dystrophies are characterized by different grade central visual loss and diffe...
It can be clinically challenging to distinguish dry age-related macular degeneration (AMD) from AMD-...
Background: North Carolina macular dystrophy (NCMD) is a rare autosomal dominant maculopathy with hi...
PURPOSE: To describe the clinical findings and to identify the genetic locus in a Dutch family with ...
Aims. We present a familial hereditary macular dystrophy, resembling North Carolina Macular Dystroph...
Retinal dystrophies are a heterogeneous group of diseases that lead to either partial or complete bl...
PURPOSE:To describe the clinical phenotype and the intrafamilial variation in retinal findings in a ...
PURPOSE: To characterize in detail the phenotype of five unrelated families with autosomal dominant ...
PURPOSE: This study aimed to identify the genetic defects in 2 families with autosomal recessive ma...
Purpose: To clinically and molecularly investigate a new family with North Carolina macular dystroph...